During the past decade, Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH" #1 sponsor was "Medical Care Center Prof. Mathey, Prof. Schofer, Ltd." with 4 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored, "C. R. Bard" with 1 trials sponsored and "Cardionovum GmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator, "FCRE (Foundation for Cardiovascular Research and Education)" with 1 trials as a collaborator, "Genae" with 1 trials as a collaborator and "KKS Netzwerk" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH" are "Coronary Artery Disease" (3 trials), "Coronary Restenosis" (3 trials), "Arterial Occlusive Diseases" (2 trials), "Arteriosclerosis" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH" in a lesser frequency.

Most popular intervention types in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH" are "Device" (8 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Admiral Xtreme" (1 trials), "Amiodarone Injection:" (1 trials), "In.Pact Admiral" (1 trials), "Lutonix Drug Coated Balloon" (1 trials) and "Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".